27 Apr Sizing Up Pneumonia Research
Article posted on April 19th, 2018.
This article was originally posted on Research Investments in Global Health.
This report summarises public and philanthropic funding for pneumonia-related research by the G20 countries between 2000 and 2015 and provides detail of findings in specific areas: funding for diagnosis, therapeutics and vaccine research, research with a focus on the paediatric community, antimicrobial resistance, and funding of pneumonia research in high-risk areas.
The analyses presented here form part of the most comprehensive data set of global investments in infection-related research undertaken to date. Overall, volume of research into pneumonia is lower than is warranted by its burden of disease when compared to other high-burden infectious diseases such as HIV, tuberculosis, and malaria.
Suggested citation – : Research Investments in Global Health Study (ResIn). Sizing up Pneumonia Research: Assessing Global Investments in Pneumonia Research 2000 – 2015. Southampton, UK. 2018. https://doi.org/10.6084/m9.figshare.6143060.v1